Class IIITerminated in FDA datasetRecall initiated Jun 10, 2013

MAX Brand RESVERATROL

Recalling firm: Healthmaxx Global Inc.

Why it was recalled

In response to a FDA inspection, the firm initiated this voluntary recall of various dietary supplements due to the following problems of mislabeling: 1) product named on the…

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Nov 14, 2014.

Check your package

Compare the exact product and package details with the label you have.

ProductMAX Brand RESVERATROL, 120 Count Capsules. Product labeling reads in part:"MAX RESVERATROL***Dietary Supplement 120 CAPSULES***Manufactured in FDA Approved Facility for:HealthMax Products Inc. Altadena, CA 91001***0 65176 30325 6".
UPC065176303256

FDA code information

Lot # A0830 UPC 0 65176 30325 6

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

MAX Brand RESVERATROL, 120 Count Capsules. Product labeling reads in part:"MAX RESVERATROL***Dietary Supplement 120 CAPSULES***Manufactured in FDA Approved Facility for:HealthMax Products Inc. Altadena, CA 91001***0 65176 30325 6".

Extracted codes and context

TypeCode / valueContext
UPC065176303256Lot # A0830 UPC 0 65176 30325 6
lotA0830Lot # A0830 UPC 0 65176 30325 6

Original FDA recall reason

In response to a FDA inspection, the firm initiated this voluntary recall of various dietary supplements due to the following problems of mislabeling: 1) product named on the label is not actual product contained; 2)ingredients listed are not actual ingredients contained.

Recall details

Recall number
F-1938-2013
Event ID
65733
FDA status
Terminated
Initiated
Jun 10, 2013
Reported
Oct 2, 2013
Classified
Sep 24, 2013
Terminated
Nov 14, 2014
Quantity
2,659 bottles
Location
Hacienda Heights, CA, United States
Initiation type
Voluntary: Firm initiated
Notification
Letter

Where it was distributed

CA, MD, and NY

FDA source record · F-1938-2013

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.